PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL

前列腺癌、肺癌、结直肠癌和卵巢癌 (PLCO) 筛查试验

• 批准号: 7377759
• 负责人: E DAVID CRAWFORD
• 金额: $ 5.07万
• 依托单位: UNIVERSITY OF COLORADO DENVER
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-01 至 2007-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7377759
• 关键词: PROSTATE; LUNG; COLORECTAL; OVARIAN; PLCO

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The following hypotheses will be tested: a) screening for prostate cancer with digital rectal exam and PSA blood test will reduce the mortality from prostate cancer; b) screening for lung cancer with chest x-ray will reduce mortality from lung cancer; c) screening for colorectal cancer with sigmoidoscopy will reduce colon/rectal cancer, and d) screening for ovarian cancer with transvaginal ultrasound and CA-125 will reduce mortality from ovarian cancer. All subjects will be age 55 - 74.

该子项目是利用 NIH/NCRR 资助的中心拨款提供的资源的众多研究子项目之一。子项目和研究者 (PI) 可能已从另一个 NIH 来源获得主要资金，因此可以在其他 CRISP 条目中出现。列出的机构是中心的机构，不一定是研究者的机构。将测试以下假设： a) 通过直肠指检和 PSA 血液检测筛查前列腺癌将降低前列腺癌的死亡率； b) 通过胸部 X 光筛查肺癌将降低肺癌死亡率； c) 使用乙状结肠镜筛查结直肠癌将减少结肠/直肠癌，d) 使用经阴道超声和 CA-125 筛查卵巢癌将降低卵巢癌的死亡率。所有受试者的年龄均为 55 - 74 岁。